Cargando…

Expanded Newborn Screening and Genomic Sequencing in Latin America and the Resulting Social Justice and Ethical Considerations

Newborn screening (NBS) has widely been utilized in developed countries as a cost-effective public health strategy that reduces morbidity and mortality. Developing countries, however, are new to the NBS scene and have their own unique challenges, both in instituting the program as well as effectivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabello, Juan F., Novoa, Fernando, Huff, Hanalise V., Colombo, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839001/
https://www.ncbi.nlm.nih.gov/pubmed/33494287
http://dx.doi.org/10.3390/ijns7010006
_version_ 1783643309783121920
author Cabello, Juan F.
Novoa, Fernando
Huff, Hanalise V.
Colombo, Marta
author_facet Cabello, Juan F.
Novoa, Fernando
Huff, Hanalise V.
Colombo, Marta
author_sort Cabello, Juan F.
collection PubMed
description Newborn screening (NBS) has widely been utilized in developed countries as a cost-effective public health strategy that reduces morbidity and mortality. Developing countries, however, are new to the NBS scene and have their own unique challenges, both in instituting the program as well as effectively acting on the results. NBS offers numerous ethical issues on a global scale, however, here we argue that there are unique ethical issues surrounding the development and expansion of newborn screening in Latin America given its highly heterogenous population. Once a NBS program is effectively instated, ethical considerations continue when pursuing expansion of screening to include further conditions. While Latin America grapples with the ethics of expanded newborn screening (ENBS), some developed countries discuss utility of genomic sequencing technologies in the newborn population. When the ability to detect further pathology is expanded, one must know what to do with this information. As rare diseases are identified either on ENBS or via genome sequencing, access to treatments for these rare diseases can be a real challenge. If we consider newborn screening as a global initiative, then we need more than a deontology approach to analyze these challenges; we need an approach that considers the unique characteristics of each territory and tremendous heterogeneity that exists prior to the implementation of these programs. As genomic technology advances further in the developed world, while some developing countries still lack even basic newborn screening, there is a further widening of the gap in global health disparities. The question is posed as to who has responsibility for these newborns’ lives on an international level. Without an approach towards newborn screening that accounts for the diverse global population, we believe optimal outcomes for newborns and families across the world will not be achieved.
format Online
Article
Text
id pubmed-7839001
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78390012021-01-28 Expanded Newborn Screening and Genomic Sequencing in Latin America and the Resulting Social Justice and Ethical Considerations Cabello, Juan F. Novoa, Fernando Huff, Hanalise V. Colombo, Marta Int J Neonatal Screen Commentary Newborn screening (NBS) has widely been utilized in developed countries as a cost-effective public health strategy that reduces morbidity and mortality. Developing countries, however, are new to the NBS scene and have their own unique challenges, both in instituting the program as well as effectively acting on the results. NBS offers numerous ethical issues on a global scale, however, here we argue that there are unique ethical issues surrounding the development and expansion of newborn screening in Latin America given its highly heterogenous population. Once a NBS program is effectively instated, ethical considerations continue when pursuing expansion of screening to include further conditions. While Latin America grapples with the ethics of expanded newborn screening (ENBS), some developed countries discuss utility of genomic sequencing technologies in the newborn population. When the ability to detect further pathology is expanded, one must know what to do with this information. As rare diseases are identified either on ENBS or via genome sequencing, access to treatments for these rare diseases can be a real challenge. If we consider newborn screening as a global initiative, then we need more than a deontology approach to analyze these challenges; we need an approach that considers the unique characteristics of each territory and tremendous heterogeneity that exists prior to the implementation of these programs. As genomic technology advances further in the developed world, while some developing countries still lack even basic newborn screening, there is a further widening of the gap in global health disparities. The question is posed as to who has responsibility for these newborns’ lives on an international level. Without an approach towards newborn screening that accounts for the diverse global population, we believe optimal outcomes for newborns and families across the world will not be achieved. MDPI 2021-01-21 /pmc/articles/PMC7839001/ /pubmed/33494287 http://dx.doi.org/10.3390/ijns7010006 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Commentary
Cabello, Juan F.
Novoa, Fernando
Huff, Hanalise V.
Colombo, Marta
Expanded Newborn Screening and Genomic Sequencing in Latin America and the Resulting Social Justice and Ethical Considerations
title Expanded Newborn Screening and Genomic Sequencing in Latin America and the Resulting Social Justice and Ethical Considerations
title_full Expanded Newborn Screening and Genomic Sequencing in Latin America and the Resulting Social Justice and Ethical Considerations
title_fullStr Expanded Newborn Screening and Genomic Sequencing in Latin America and the Resulting Social Justice and Ethical Considerations
title_full_unstemmed Expanded Newborn Screening and Genomic Sequencing in Latin America and the Resulting Social Justice and Ethical Considerations
title_short Expanded Newborn Screening and Genomic Sequencing in Latin America and the Resulting Social Justice and Ethical Considerations
title_sort expanded newborn screening and genomic sequencing in latin america and the resulting social justice and ethical considerations
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839001/
https://www.ncbi.nlm.nih.gov/pubmed/33494287
http://dx.doi.org/10.3390/ijns7010006
work_keys_str_mv AT cabellojuanf expandednewbornscreeningandgenomicsequencinginlatinamericaandtheresultingsocialjusticeandethicalconsiderations
AT novoafernando expandednewbornscreeningandgenomicsequencinginlatinamericaandtheresultingsocialjusticeandethicalconsiderations
AT huffhanalisev expandednewbornscreeningandgenomicsequencinginlatinamericaandtheresultingsocialjusticeandethicalconsiderations
AT colombomarta expandednewbornscreeningandgenomicsequencinginlatinamericaandtheresultingsocialjusticeandethicalconsiderations